BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23063634)

  • 1. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.
    Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
    J Urol; 2013 Mar; 189(3):867-70. PubMed ID: 23063634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on "Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare." Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM, Department of Urology, New York University, New York, NY. J Urol 2013; 189(3):867-70. [Epub 2012 Oct 9]. doi: 10.1016/j.juro.2012.10.005.
    Eggener S
    Urol Oncol; 2014 Aug; 32(6):935-6. PubMed ID: 25087672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications after prostate biopsy: data from SEER-Medicare.
    Loeb S; Carter HB; Berndt SI; Ricker W; Schaeffer EM
    J Urol; 2011 Nov; 186(5):1830-4. PubMed ID: 21944136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare: S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker and E. M. Schaeffer J Urol 2013; 189: 867-870.
    Singh I; Gautam L
    J Urol; 2013 Oct; 190(4):1439-40. PubMed ID: 23886882
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
    Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
    J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States.
    Loeb S; Walter D; Curnyn C; Gold HT; Lepor H; Makarov DV
    J Urol; 2016 Sep; 196(3):721-6. PubMed ID: 26946161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy.
    Kibel AS
    J Urol; 2013 Mar; 189(3):796-7. PubMed ID: 23246850
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy: A. S. Kibel J Urol 2013; 189: 796-797.
    Horan AH
    J Urol; 2013 Sep; 190(3):1139. PubMed ID: 23583228
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply by authors.
    J Urol; 2013 Oct; 190(4):1440. PubMed ID: 23886879
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply by author.
    J Urol; 2013 Sep; 190(3):1140. PubMed ID: 23770372
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk Factors for Infection after Prostate Biopsy in the United States.
    Shoag JE; Gaffney C; Pantuck M; Sun T; Gorin M; Schaeffer E; Sedrakyan A; Vickers A; Hu J
    Urology; 2020 Apr; 138():113-118. PubMed ID: 31899233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
    Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
    JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance.
    Ehdaie B; Vertosick E; Spaliviero M; Giallo-Uvino A; Taur Y; O'Sullivan M; Livingston J; Sogani P; Eastham J; Scardino P; Touijer K
    J Urol; 2014 Mar; 191(3):660-4. PubMed ID: 24018237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Patient Burden of Bladder Outlet Obstruction after Prostate Cancer Treatment.
    Liberman D; Jarosek S; Virnig BA; Chu H; Elliott SP
    J Urol; 2016 May; 195(5):1459-1463. PubMed ID: 26682759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of increasing detection in the rising incidence of prostate cancer.
    Potosky AL; Miller BA; Albertsen PC; Kramer BS
    JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
    Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
    J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? Analysis by the number of cores taken at initial biopsy.
    Park M; You D; Yoon JH; Jeong IG; Song C; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 May; 109(10):1474-9. PubMed ID: 21933324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer.
    Ganeswaran D; Sweeney C; Yousif F; Lang S; Goodman C; Nabi G
    World J Urol; 2014 Apr; 32(2):309-15. PubMed ID: 22736233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.
    Loeb S; van den Heuvel S; Zhu X; Bangma CH; Schröder FH; Roobol MJ
    Eur Urol; 2012 Jun; 61(6):1110-4. PubMed ID: 22244150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
    Naya Y; Ayala AG; Tamboli P; Babaian RJ
    Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.